Correspondence 0001193125-24-181621 from Climb Bio, Inc. (CLYM) (CIK 0001768446) (CLYM)
Climb Bio, Inc. (CLYM) (CIK 0001768446)
Date: July 19, 2024 · CIK: 0001768446 · Accession: 0001193125-24-181621
AI Filing Summary & Sentiment
File numbers found in text: 333-280784
Letter
Re: Eliem Therapeutics, Inc.
July 19, 2024
VIA EDGAR SUBMISSION
U.S. Securities and Exchange Commission
Division of Corporation Finance, Office of Life Sciences
100 F Street, NE
Washington, DC 20549
Attention: Laura Crotty
Registration Statement on Form S-3
Filed July 12, 2024
File No. 333-280784
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Eliem Therapeutics, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-280784), so that it may become effective at 4:00 p.m., Eastern Time, on July 23, 2024, or as soon as practicable thereafter.
Very truly yours,
ELIEM THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP July 19, 2024 VIA EDGAR SUBMISSION U.S. Securities and Exchange Commission Division of Corporation Finance, Office of Life Sciences 100 F Street, NE Washington, DC 20549 Attention: Laura Crotty Re: Eliem Therapeutics, Inc. Registration Statement on Form S-3 Filed July 12, 2024 File No. 333-280784 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Eliem Therapeutics, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-280784), so that it may become effective at 4:00 p.m., Eastern Time, on July 23, 2024, or as soon as practicable thereafter. Very truly yours, ELIEM THERAPEUTICS, INC. By: /s/ Aoife Brennan Name: Aoife Brennan, M.B., Ch.B. Title: President and Chief Executive Officer